chr7-99861778-A-G

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_057095.3(CYP3A43):​c.1192A>G​(p.Ile398Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)

Consequence

CYP3A43
NM_057095.3 missense

Scores

19

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -1.18
Variant links:
Genes affected
CYP3A43 (HGNC:17450): (cytochrome P450 family 3 subfamily A member 43) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The encoded protein has a low level of testosterone hydroxylase activity, and may play a role in aging mechanisms and cancer progression. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Alternate splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.06827453).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
CYP3A43NM_057095.3 linkuse as main transcriptc.1192A>G p.Ile398Val missense_variant 11/13 ENST00000354829.7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
CYP3A43ENST00000354829.7 linkuse as main transcriptc.1192A>G p.Ile398Val missense_variant 11/131 NM_057095.3 A1Q9HB55-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsAug 13, 2021The c.1192A>G (p.I398V) alteration is located in exon 11 (coding exon 11) of the CYP3A43 gene. This alteration results from a A to G substitution at nucleotide position 1192, causing the isoleucine (I) at amino acid position 398 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.087
BayesDel_addAF
Benign
-0.27
T
BayesDel_noAF
Benign
-0.63
CADD
Benign
0.021
DANN
Benign
0.19
DEOGEN2
Benign
0.013
T;.;.;.;.;.
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.016
N
LIST_S2
Benign
0.60
T;T;T;T;T;T
M_CAP
Benign
0.0092
T
MetaRNN
Benign
0.068
T;T;T;T;T;T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
0.035
N;.;.;.;N;N
MutationTaster
Benign
1.0
N;N;N;N;N;N;N
PrimateAI
Benign
0.25
T
PROVEAN
Benign
0.18
N;N;N;N;N;N
REVEL
Benign
0.041
Sift
Benign
1.0
T;T;T;T;T;T
Sift4G
Benign
1.0
T;T;T;T;T;T
Polyphen
0.0050
B;.;.;.;B;.
Vest4
0.032
MutPred
0.49
Gain of phosphorylation at Y399 (P = 0.1252);.;.;.;Gain of phosphorylation at Y399 (P = 0.1252);Gain of phosphorylation at Y399 (P = 0.1252);
MVP
0.32
MPC
0.023
ClinPred
0.052
T
GERP RS
1.5
Varity_R
0.034
gMVP
0.32

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr7-99459401; API